Add Yahoo as a preferred source to see more of our stories on Google. Big news for those concerned about their heart health: Pharmaceutical company Merck has created a new pill called enlicitide, ...

Add Yahoo as a preferred source to see more of our stories on Google. A new Merck pill called enlicitide slashes levels of harmful LDL cholesterol by up to 60%, similar to injectable PCSK9 drugs ...

Merck & Co. Inc. (NYSE:MRK) on Tuesday shared topline results from the Phase 3 CORALreef Lipids trial evaluating the safety and efficacy of enlicitide decanoate for hypercholesterolemia on a moderate ...

An experimental once-a-day tablet has slashed 'bad' cholesterol levels by approximately 60%, potentially saving millions from heart attacks and strokes. The pill has recently passed a large phase ...

Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with FDA approval for subcutaneous use. The LIBerate Program showed sustained ...

Merck’s new pill, enlicitide, lowered LDL cholesterol by up to 60% in a new trial The pill works just as well as traditional PCSK9 injections but could cost less Researchers hope to receive federal ...

Sixteen received the injections intravenously and the others got simple injections that delivered the drug just underneath the skin. After the injections, bad cholesterol was measured frequently for ...

Heart attacks and strokes often seem to happen suddenly, but they usually develop slowly over many years. Damage builds up ...

US health guidelines say people should start having their levels tested from the age of 30 ...

Big news for those concerned about their heart health: Pharmaceutical company Merck has created a new pill called enlicitide, which promises to lower "bad" cholesterol as effectively as injectable ...